May 22, 2020 / 12:58 PM / in 4 days

BRIEF-Nektar Therapeutics Announces Publication Of Results From Phase 1 Dose-Escalation Study In 'Cancer Discovery' Journal

May 22 (Reuters) - Nektar Therapeutics:

* NEKTAR THERAPEUTICS ANNOUNCES PUBLICATION OF RESULTS FROM PHASE 1 DOSE-ESCALATION STUDY FOR BEMPEGALDESLEUKIN PLUS NIVOLUMAB IN ‘CANCER DISCOVERY’ JOURNAL Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below